Current opinions for the management of asthma associated with ear, nose and throat comorbidities
(2018) European Respiratory Review — Vol. 27, n° 150, p. 180056 (2018)
Files
Asthme-ENT.pdf
Open Access - Adobe PDF
- 389.89 KB
Details
- Authors
- Abstract
- ENT comorbidities contribute to poor asthma control. These comorbidities are "treatable traits", adding impetus to their evaluation and management to improve asthma outcomes. ABSTRACT Ear, nose and throat (ENT) comorbidities are common in patients with asthma and are frequently associated with poorer asthma outcomes. All these comorbidities are "treatable traits" in asthma. Identification and management of these disorders may spare medication usage and contribute to improved asthma control and quality of life, and a decrease in exacerbation rates. This review summarises recent data about the prevalence, clinical impact and treatment effects of ENT comorbidities in asthma including allergic rhinitis, chronic rhinosinusitis with and without nasal polyposis, aspirin-exacerbated respiratory disease, obstructive sleep apnoea and vocal cord dysfunction. Many of these comorbidities are possible to be managed by the pulmonologist, but the collaboration with the ENT specialist is essential for patients with chronic rhinosinusitis or vocal cord dysfunction. Further rigorous research is needed to study the efficacy of comorbidity treatment to improve asthma outcomes, in particular with the development of biotherapies in severe asthma that can also be beneficial in some ENT diseases.
- Affiliations
Citations
Tiotiu-Cepuc, I., Plavec, D., Novakova, S., Mihaicuta, S., Novakova, P., Labor, M., & Bikov, A. (2018). Current opinions for the management of asthma associated with ear, nose and throat comorbidities. European Respiratory Review, 27(150), 180056. https://doi.org/10.1183/16000617.0056-2018 (Original work published 2018)